Literature DB >> 16164962

Variability of biological effects of silicas: different degrees of activation of the fifth component of complement by amorphous silicas.

Mario Governa1, Monica Amati, Ivana Fenoglio, Matteo Valentino, Sabrina Coloccini, Lucia Bolognini, Gian Carlo Botta, Monica Emanuelli, Francesca Pierella, Anna Rita Volpe, Paola Astolfi, Marco Carmignani, Bice Fubini.   

Abstract

A biogenic and a pyrogenic amorphous silica were incubated in normal human plasma and compared on a per unit surface basis for their ability to split C5 molecules and yield small C5a peptides. Since C5a peptides induce selective chemotactic attraction of polymorphonuclear leukocytes (PMN), measurement of PMN-induced chemotaxis was used as an index of C5 activation. Though to a lesser extent than the crystalline forms, amorphous silicas can promote the cleavage of C5 protein and generation of C5a-like fragment. The biogenic silica, which differs from the pyrogenic variety in particle shape, level of contaminants, and degree of surface hydrophilicity, besides specific surface, induced a greater response. Both silicas activated C5 through a process which seems to involve multiple events similar to those induced by crystalline silica. C5 molecules are adsorbed and hydroxyl radicals are generated through Haber Weiss cycles catalyzed by the redox-active iron present at the particle surface either as trace impurities or chelated from plasma by silanol groups. In turn, these radicals convert native C5 to an oxidized C5-like form C5(H2O2). Finally, C5(H2O2) is cleaved by protease enzymatic action of plasma kallikrein activated by the same silica dusts, yielding a product, C5a(H2O2), having the same functional characteristic as C5a.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16164962     DOI: 10.1016/j.taap.2005.01.019

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  5 in total

1.  The biocompatibility of mesoporous silicates.

Authors:  Sarah P Hudson; Robert F Padera; Robert Langer; Daniel S Kohane
Journal:  Biomaterials       Date:  2008-10       Impact factor: 12.479

2.  Macrophage silica nanoparticle response is phenotypically dependent.

Authors:  Heather L Herd; Kristopher T Bartlett; Joshua A Gustafson; Lawrence D McGill; Hamidreza Ghandehari
Journal:  Biomaterials       Date:  2015-03-23       Impact factor: 12.479

Review 3.  Recent developments in low molecular weight complement inhibitors.

Authors:  Hongchang Qu; Daniel Ricklin; John D Lambris
Journal:  Mol Immunol       Date:  2009-10-02       Impact factor: 4.407

Review 4.  Function, structure and therapeutic potential of complement C5a receptors.

Authors:  P N Monk; A-M Scola; P Madala; D P Fairlie
Journal:  Br J Pharmacol       Date:  2007-07-02       Impact factor: 8.739

Review 5.  Particle toxicology and health - where are we?

Authors:  Michael Riediker; Daniele Zink; Wolfgang Kreyling; Günter Oberdörster; Alison Elder; Uschi Graham; Iseult Lynch; Albert Duschl; Gaku Ichihara; Sahoko Ichihara; Takahiro Kobayashi; Naomi Hisanaga; Masakazu Umezawa; Tsun-Jen Cheng; Richard Handy; Mary Gulumian; Sally Tinkle; Flemming Cassee
Journal:  Part Fibre Toxicol       Date:  2019-04-23       Impact factor: 9.400

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.